We have a new SMS number for mobile alerts. From the USA or CANADA simply text the keyword “Traders” to (877) 321-1383
Market Update and Recent News from Actinium (NYSE: ATNM)
New report coming the week of 11-23-20
Good day everyone,
The markets have gained significantly over the past ten days and that is a welcome direction.
Nov. 2nd Now Gain
DJIA 26957 29218 8.3%
NASDAQ 10921 11826 8.3%
S&P 500 3297 3553 7.7%
2020 has been a horrible year for many of us. Sick and deceased loved ones, jobs lost and those still employed working on Zoom or wearing masks, a tumultuous presidential election, and a myriad of other stressful situations.
But through this turmoil, the markets have been keeping their head above water. We believe there is an important lesson to be learned this year and that is “markets tend to react to financial metrics and not so much social problems”.
It wasn’t always that way. Uncertainty has caused a few market corrections in the past. The 1970’s were a decade that saw a big drop in the averages as we wrestled with Vietnam, Watergate, and the revolution in the Middle East. The early 2000’s saw a significant drop in the markets due to the impact of 911.
The largest market drop in recent history was caused by the mortgage crisis of 2008, a financial disaster that directly impacted Wall Street.
The biggest change in our view of our social and financial lives has been the ubiquitous smart phone. Remember, these devices have only been in widespread use for a decade. Today news comes instantly, and you can manage your stocks and monitor the markets from virtually anywhere.
We would like to give you an update on a development at Actinium Pharmaceuticals (ATNM), a value company we want to keep you updated on.
On Wednesday, the company hosted an “ARC CD33 Combination Trial KOL (key opinion leaders) Call” and we want to give you a brief update on that news. The event featured key opinion leaders Dr. Ehab Atallah, Medical College of Wisconsin, and Dr. Gary Schiller, UCLA Medical Center.
These two speakers have discussed their experience with collaborative clinical studies they are involved in with ATNM ARC therapies and combinations with other ARC therapies being developed. The AWE delivery system is also discussed.
There is an extended discussion of the application of Actimab-A and the impact it has in improved applications of chemotherapy in AML.
The KOL Call is something you must listen to if you want a better understanding of the Actinium potential. We have linked the call below:
https://onecast.thinkpragmatic.com/ses/7tNMY9WhasQuBZasP4Ig-A~~?ek=4586f293-4501-4a39-927a-7732330e538e
Actinium is trading 3.5% higher on the day at $11.74/share. We are watching for a sustained break above $12/share for the next leg up.
The Traders News Group
__________________________________________________
Privacy Policy and Disclaimer
Your Consent
By using our site, you consent to our online privacy policy and disclaimer.
Do we disclose any information to outside parties?
We hate spam and we do not sell, trade, or otherwise transfer to outside parties your personally identifiable information.
What information do we collect?
We collect information from you when you subscribe to our newsletter or fill out a form. This includes your email address only.
When registering on our site, as appropriate, you may be asked to enter your: e-mail address
What do we use your information for?
When we collect your email it is used for one purpose to send you the free information you requested about small cap stocks. Please read our disclaimer carefully before viewing our emails.
Your information, whether public or private, will not be sold, exchanged, transferred, or given to any other company for any reason whatsoever, other than for the express purpose of delivering the information on small cap stocks that you requested.
We send periodic emails
The email address you provide may be used to send you information, respond to inquiries, and/or other requests or questions.
How do we protect your information?
We implement a variety of security measures to maintain the safety of your personal information when you enter, submit, your email address. We use a secure third party to send email to you.
Because we value your privacy we have taken the necessary precautions to be in compliance with the California Online Privacy Protection Act. We therefore will not distribute your personal information to outside parties without your consent.
Online Privacy Policy Only
This online privacy policy applies only to information collected through our website and not to information collected offline.
Contacting Us
If there are any questions regarding this privacy policy or disclaimer you may contact us using the information below.
Editor@TradersNewsSource.com
Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.
PLEASE NOTE WELL: TNS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. TNS LLC’s parent company has been co.mpensated twenty three thousand three hundred thirty three dollars cas.h via bank wir.e by legends media llc for this week and our previous week of coverage on atnm. The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.
TNS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA. TNS LLC is not a Broker/Dealer and does not engage in high frequency trading.
